Pregnant Women clinical trials

Explore recruiting pregnant women clinical trials.

Recruiting pregnant women studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pregnant Women trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Congenital CMV treated with valaciclovir during pregnancy: a prospective cohort study

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

C1091009 - A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Finland, Netherlands, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase IV, multicenter, open-label, single-arm, open-label study to evaluate the safety of almagate in pregnant women with acidity and heartburn, and on perinatal outcomes in the fetus and newborn

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Comparison of the efficacy and safety of valaciclovir in the prevention of transmission and treatment of intrauterine infection in pregnant women with primary cytomegalovirus infection depending on the used drug dose - the first Polish non-commercial non-inferiority clinical trial.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATIMMUNE)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA)

Spain, Ireland, Netherlands, Belgium, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Pregnant Women trials by city

Pregnant Women in Toronto Pregnant Women in Vancouver Pregnant Women in Montreal Pregnant Women in Calgary Pregnant Women in Edmonton Pregnant Women in Ottawa Pregnant Women in Winnipeg Pregnant Women in Quebec City Pregnant Women in Hamilton Pregnant Women in Kitchener Pregnant Women in London Pregnant Women in Halifax Pregnant Women in New York Pregnant Women in Los Angeles Pregnant Women in Chicago Pregnant Women in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease